
Chinook Therapeutics Investor Relations Material
Latest events

Investor Update
Chinook Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Chinook Therapeutics Inc
Access all reports
Chinook Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's pipeline targets rare, severe chronic kidney conditions, aiming to address unmet medical needs in areas such as immunoglobulin A (IgA) nephropathy and other forms of glomerular diseases. Chinook leverages advanced research technologies and a deep understanding of kidney biology to develop innovative therapies designed to slow or prevent disease progression. The company is headquartered in Seattle, Washington, and its shares are listed on the Nasdaq.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
KDNY
Country
🇺🇸 United States